The Bioregulator Vesilut: Bladder Research

The study that is being conducted on Vesilut, which is a bioregulator peptide that Khavinson produced, is largely focused on the possible function that it may play in regulating the prostate gland and the urinary system. It has been suggested by scientific research that Vesilut may be useful in reducing the symptoms that are associated with problems with the urinary system and the bladder. Furthermore, Vesilut and other cytokines have suggested that they may alleviate prostate dysfunction. Studies suggest that this may be accomplished by increasing the microcirculation inside the prostate and simultaneously decreasing the proliferation of aberrant cells. Changing the density of chromosomes and epigenetic factors is a frequent method of cellular control seen in Khavinson peptides. This impact may be linked to altered chromosome density and epigenetic factors.

Vesilut Peptide: What is it?


There are two types of dipeptides: localized to certain organs and those extensively diffused across the organism’s other tissues. Vesilut is classified as belonging to the latter group since it  is considered to be distributed throughout the organism. Vesilut is one of the Khavinson peptides that has received the least research. Yet, research suggests it may positively affect the bladder tissues and the genitourinary system. It has been hypothesized that Vesilut may improve bladder function, and may be of potential relevance in studies within the context of illnesses such as chronic cystitis, benign prostatic hyperplasia (BPH), and various urinary difficulties. Furthermore, investigations purport that the peptide may have remarkable organotypic potential on the prostate, which may contribute to preventing aberrant cell proliferation and prostate enlargement. This improvement in microcirculation may be the mechanism by which the peptide may potentially exert these actions.

Findings imply that Vesilut and other cytokines may have impacts on sperm quality and fertility. It has been indicated, via research carried out in Russia, that the presentation of cytokines may result in an increase in the production of sperm, an improvement in the function of sperm, and an increase in the viability of sperm while simultaneously lowering the quantity of defective sperm. An increase in fertility may be attributed to the cumulative impact of these factors.

Of particular interest is that the Glu-Asp peptide and twelve other dipeptides have been classified as the components responsible for a pleasing taste (as seen in animal models) in various settings. The potential of producing such a flavor implies that these peptides may be promoted via the mechanisms of taste acquired through evolution. Even though this does not conclusively indicate their significance in basic biochemical processes, it has been suggested that Vesilut and other cytokines may be active.

Vesilut Peptide and Smooth Muscle Systems

Vesilut, a Khavinson peptide, has suggested that it may be practical in various physiolocial areas, notably regarding the functioning of muscles and blood vessels, the function of the prostate, and fertility. To summarize its possible results and effects, the following are some major points:

  • Vesilut is thought to have anti-aggregation effects on muscular tissues, notably in the bladder wall, which might result in feelings of muscle relaxation. It is theorized to do this by interfering with the process of aggregation, which stops the breakdown of glycogen, which is necessary for muscle contraction. As a result of this action, smooth muscle relaxation is induced, which provides relief from spasms and pain, especially in the urinary system.
  • The properties of Vesilut have been speculated to extend to the vascular system, which may increase smooth muscle relaxation in blood vessels. This is believed to be advantageous to the function of the vascular system. This relaxation results in a decrease in blood pressure, a drop in the amount of energy required by the heart, and an improvement in the transport of nutrients to various organs. Due to its potential to promote vascular function, Vesilut has been asserted to have the potential to contribute to long-term well-being, notably in the kidneys, brain, and heart.
  • It is believed that the microvascular effects of Vesilut could be practical for the prostate gland, also known as the prostate. Through the reduction of inflammation, the enhancement of blood flow, and the assistance in eliminating pollutants, it may promote circulation inside the prostate. These actions may lead to a decrease in the size and fibrosis of the prostate.
  • There is speculation that Vesilut, which may help in the context of prostatitis and improve microcirculation inside the prostate, might aid fertility. Scientists speculate it may result in enhanced sperm levels and better sperm viability.

Cytomedine Peptide: Vesilut is classified as a cytokine peptide, often referred to as a peptide bioregulator that may aid in preventing premature aging. It is possible that its capacity to interfere with cellular processes, such as microcirculation and cell proliferation, is one of the factors contributing to its many physiological potential properties.

In conclusion, Vesilut has been hypothesized to have a complex role in promoting the physiological function of the organism, with prospective uses in muscle relaxation, vascular function, prostate function, and fertility. Researchers speculate that Vesilut is a peptide with the potential to have a variety of practical impacts on the organism’s physiological systems; nevertheless, further study is required to fully understand its mechanisms.

Researchers interested in Vesilut for sale may find it online on the Core Peptides website with the highest quality and lowest prices.


[i] Heidenreich E, Pfeffer T, Kracke T, Mechtel N, Nawroth P, Hoffmann GF, Schmitt CP, Hell R, Poschet G, Peters V. A Novel UPLC-MS/MS Method Identifies Organ-Specific Dipeptide Profiles. Int J Mol Sci. 2021 Sep 15;22(18):9979. doi: 10.3390/ijms22189979. PMID: 34576148; PMCID: PMC8465603.

[ii] Neymark BA, Neymark AI, Davydov AV, Klepikova II, Nozdrachev NA, Razdorskaya MV. [ROLE OF CYTOMEDINES IN THE TREATMENT OF PATIENTS WITH CHRONIC PROSTATITIS ASSOCIATED WITH IMPAIRED SPERMATOGENESIS]. Urologiia. 2015 Sep-Oct;(5):70, 72-3. Russian. PMID: 26859942.

[iii] Dzhokhadze TA, Buadze TZh, Gaĭozishvili MN, Baratashvili NA, Lezhava TA. [Deheterochromatinization of the chromatin in old age induced by oligopeptide bioregulator (Lys-Glu-Asp-Pro)]. Georgian Med News. 2012 Nov;(212):76-82. Russian. PMID: 23221144.

[iv] Vladimir Khavinson has a “M.D., S.M.” from the Kirov Medical Military Academy (Leningrad). “M.D., S.M. Vladimir Khavinson” currently works at the International Association of Gerontology and Geriatrics and has 1 year experience in researching Peptide transport mechanisms at the Pavlov Institute of Physiology of the Russian Academy of Sciences. One of their notable works include Transport of Biologically Active Ultrashort Peptides Using POT and LAT Carriers.

[v] Borovskaya, T. G., Pakhomova, A. V., Vychuzhanina, A. V., Poluektova, M. E., Fomina, T. I., Ermolaeva, L. A., … & Neplochov, E. A. (2013). Experimental studying of the drug efficiency Prostamax in the therapy of chronic aseptic prostatitis and its complications. Modern Research in Inflammation, 2013.